Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 107

Published Date: 31 Jan 2021

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Contract Research Organization (CRO) and CDMO for Pharmaceutical market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Contract Research Organization (CRO) and CDMO for Pharmaceutical size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Contract Research Organization (CRO) and CDMO for Pharmaceutical market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Contract Research Organization (CRO) and CDMO for Pharmaceutical market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Development
    API production
    Formulation

Market segment by Application, can be divided into
    Pharmaceutical
    Biopharmaceutical

Market segment by players, this report covers
    Recipharm
    AMRI3
    Patheon
    Aenova
    Catalent
    Amatsigroup
    WuXi PharmaTech
    Strides Shasun
    Piramal
    Siegfried

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Contract Research Organization (CRO) and CDMO for Pharmaceutical
    1.2 Classification of Contract Research Organization (CRO) and CDMO for Pharmaceutical by Type
        1.2.1 Overview: Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Type in 2020
        1.2.3 Development
        1.2.4 API production
        1.2.5 Formulation
    1.3 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market by Application
        1.3.1 Overview: Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Pharmaceutical
        1.3.3 Biopharmaceutical
    1.4 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size & Forecast
    1.5 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast by Region
        1.5.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Region, (2016-2021)
        1.5.3 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Prospect (2016-2026)
        1.5.4 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Prospect (2016-2026)
        1.5.6 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Drivers
        1.6.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Restraints
        1.6.3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Trends Analysis

2 Company Profiles
    2.1 Recipharm
        2.1.1 Recipharm Details
        2.1.2 Recipharm Major Business
        2.1.3 Recipharm Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.1.4 Recipharm Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Recipharm Recent Developments and Future Plans
    2.2 AMRI3
        2.2.1 AMRI3 Details
        2.2.2 AMRI3 Major Business
        2.2.3 AMRI3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.2.4 AMRI3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 AMRI3 Recent Developments and Future Plans
    2.3 Patheon
        2.3.1 Patheon Details
        2.3.2 Patheon Major Business
        2.3.3 Patheon Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.3.4 Patheon Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Patheon Recent Developments and Future Plans
    2.4 Aenova
        2.4.1 Aenova Details
        2.4.2 Aenova Major Business
        2.4.3 Aenova Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.4.4 Aenova Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Aenova Recent Developments and Future Plans
    2.5 Catalent
        2.5.1 Catalent Details
        2.5.2 Catalent Major Business
        2.5.3 Catalent Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.5.4 Catalent Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Catalent Recent Developments and Future Plans
    2.6 Amatsigroup
        2.6.1 Amatsigroup Details
        2.6.2 Amatsigroup Major Business
        2.6.3 Amatsigroup Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.6.4 Amatsigroup Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Amatsigroup Recent Developments and Future Plans
    2.7 WuXi PharmaTech
        2.7.1 WuXi PharmaTech Details
        2.7.2 WuXi PharmaTech Major Business
        2.7.3 WuXi PharmaTech Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.7.4 WuXi PharmaTech Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 WuXi PharmaTech Recent Developments and Future Plans
    2.8 Strides Shasun
        2.8.1 Strides Shasun Details
        2.8.2 Strides Shasun Major Business
        2.8.3 Strides Shasun Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.8.4 Strides Shasun Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Strides Shasun Recent Developments and Future Plans
    2.9 Piramal
        2.9.1 Piramal Details
        2.9.2 Piramal Major Business
        2.9.3 Piramal Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.9.4 Piramal Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Piramal Recent Developments and Future Plans
    2.10 Siegfried
        2.10.1 Siegfried Details
        2.10.2 Siegfried Major Business
        2.10.3 Siegfried Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.10.4 Siegfried Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Siegfried Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Players Market Share
        3.2.2 Top 10 Contract Research Organization (CRO) and CDMO for Pharmaceutical Players Market Share
        3.2.3 Market Competition Trend
    3.3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Market Share by Type (2016-2021)
    4.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Application (2016-2021)
    5.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2016-2026)
    6.2 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2016-2026)
    6.3 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country
        6.3.1 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2016-2026)
        6.3.2 United States Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2016-2026)
        6.3.3 Canada Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2016-2026)
        6.3.4 Mexico Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2016-2026)
    7.2 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2016-2026)
    7.3 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country
        7.3.1 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2016-2026)
        7.3.2 Germany Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2016-2026)
        7.3.3 France Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2016-2026)
        7.3.5 Russia Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2016-2026)
        7.3.6 Italy Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2016-2026)
    8.2 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2016-2026)
    8.3 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Region
        8.3.1 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Region (2016-2026)
        8.3.2 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2016-2026)
        8.3.3 Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2016-2026)
        8.3.4 South Korea Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2016-2026)
        8.3.5 India Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2016-2026)
        8.3.7 Australia Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2016-2026)
    9.2 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2016-2026)
    9.3 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country
        9.3.1 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2016-2026)
        9.3.2 Brazil Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2016-2026)
        9.3.3 Argentina Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2016-2026)
    10.2 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2016-2026)
    10.3 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country
        10.3.1 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2016-2026)
        10.3.2 Turkey Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2016-2026)
        10.3.4 UAE Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) by Region (2016-2021)
    Table 5. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Region (2021-2026)
    Table 6. Recipharm Corporate Information, Head Office, and Major Competitors
    Table 7. Recipharm Major Business
    Table 8. Recipharm Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 9. Recipharm Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. AMRI3 Corporate Information, Head Office, and Major Competitors
    Table 11. AMRI3 Major Business
    Table 12. AMRI3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 13. AMRI3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Patheon Corporate Information, Head Office, and Major Competitors
    Table 15. Patheon Major Business
    Table 16. Patheon Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 17. Patheon Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. Aenova Corporate Information, Head Office, and Major Competitors
    Table 19. Aenova Major Business
    Table 20. Aenova Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 21. Aenova Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. Catalent Corporate Information, Head Office, and Major Competitors
    Table 23. Catalent Major Business
    Table 24. Catalent Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 25. Catalent Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. Amatsigroup Corporate Information, Head Office, and Major Competitors
    Table 27. Amatsigroup Major Business
    Table 28. Amatsigroup Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 29. Amatsigroup Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. WuXi PharmaTech Corporate Information, Head Office, and Major Competitors
    Table 31. WuXi PharmaTech Major Business
    Table 32. WuXi PharmaTech Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 33. WuXi PharmaTech Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. Strides Shasun Corporate Information, Head Office, and Major Competitors
    Table 35. Strides Shasun Major Business
    Table 36. Strides Shasun Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 37. Strides Shasun Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. Piramal Corporate Information, Head Office, and Major Competitors
    Table 39. Piramal Major Business
    Table 40. Piramal Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 41. Piramal Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. Siegfried Corporate Information, Head Office, and Major Competitors
    Table 43. Siegfried Major Business
    Table 44. Siegfried Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 45. Siegfried Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) by Players (2019-2021)
    Table 47. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Share by Players (2019-2021)
    Table 48. Breakdown of Contract Research Organization (CRO) and CDMO for Pharmaceutical by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 49. Contract Research Organization (CRO) and CDMO for Pharmaceutical Players Head Office, Products and Services Provided
    Table 50. Contract Research Organization (CRO) and CDMO for Pharmaceutical Mergers & Acquisitions in the Past Five Years
    Table 51. Contract Research Organization (CRO) and CDMO for Pharmaceutical New Entrants and Expansion Plans
    Table 52. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) by Type (2016-2021)
    Table 53. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Share by Type (2016-2021)
    Table 54. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Forecast by Type (2021-2026)
    Table 55. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2016-2021)
    Table 56. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Forecast by Application (2021-2026)
    Table 57. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2016-2021) & (USD Million)
    Table 58. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2021-2026) & (USD Million)
    Table 59. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2016-2021) & (USD Million)
    Table 60. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2021-2026) & (USD Million)
    Table 61. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2016-2021) & (USD Million)
    Table 62. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2021-2026) & (USD Million)
    Table 63. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2016-2021) & (USD Million)
    Table 64. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2021-2026) & (USD Million)
    Table 65. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2016-2021) & (USD Million)
    Table 66. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2021-2026) & (USD Million)
    Table 67. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2016-2021) & (USD Million)
    Table 68. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2021-2026) & (USD Million)
    Table 69. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2016-2021) & (USD Million)
    Table 70. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2021-2026) & (USD Million)
    Table 71. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2016-2021) & (USD Million)
    Table 72. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2021-2026) & (USD Million)
    Table 73. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Region (2016-2021) & (USD Million)
    Table 74. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Region (2021-2026) & (USD Million)
    Table 75. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2016-2021) & (USD Million)
    Table 76. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2021-2026) & (USD Million)
    Table 77. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2016-2021) & (USD Million)
    Table 78. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2021-2026) & (USD Million)
    Table 79. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2016-2021) & (USD Million)
    Table 80. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2021-2026) & (USD Million)
    Table 81. Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2016-2021) & (USD Million)
    Table 82. Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Type (2021-2026) & (USD Million)
    Table 83. Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2016-2021) & (USD Million)
    Table 84. Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Application (2021-2026) & (USD Million)
    Table 85. Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2016-2021) & (USD Million)
    Table 86. Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. Contract Research Organization (CRO) and CDMO for Pharmaceutical Picture
    Figure 2. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Type in 2020
    Figure 3. Development
    Figure 4. API production
    Figure 5. Formulation
    Figure 6. Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Application in 2020
    Figure 7. Pharmaceutical Picture
    Figure 8. Biopharmaceutical Picture
    Figure 9. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 10. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Forecast (2016-2026) & (USD Million)
    Figure 11. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Region (2016-2026)
    Figure 12. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Region in 2020
    Figure 13. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 14. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 15. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 16. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 17. Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 18. Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Drivers
    Figure 19. Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Restraints
    Figure 20. Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Trends
    Figure 21. Recipharm Recent Developments and Future Plans
    Figure 22. AMRI3 Recent Developments and Future Plans
    Figure 23. Patheon Recent Developments and Future Plans
    Figure 24. Aenova Recent Developments and Future Plans
    Figure 25. Catalent Recent Developments and Future Plans
    Figure 26. Amatsigroup Recent Developments and Future Plans
    Figure 27. WuXi PharmaTech Recent Developments and Future Plans
    Figure 28. Strides Shasun Recent Developments and Future Plans
    Figure 29. Piramal Recent Developments and Future Plans
    Figure 30. Siegfried Recent Developments and Future Plans
    Figure 31. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Share by Players in 2020
    Figure 32. Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 33. Global Top 3 Players Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share in 2020
    Figure 34. Global Top 10 Players Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share in 2020
    Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 36. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Share by Type in 2020
    Figure 37. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share Forecast by Type (2021-2026)
    Figure 38. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Share by Application in 2020
    Figure 39. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share Forecast by Application (2021-2026)
    Figure 40. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Type (2016-2026)
    Figure 41. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Application (2016-2026)
    Figure 42. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Country (2016-2026)
    Figure 43. United States Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 44. Canada Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 45. Mexico Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 46. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Type (2016-2026)
    Figure 47. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Application (2016-2026)
    Figure 48. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Country (2016-2026)
    Figure 49. Germany Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. France Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. United Kingdom Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. Russia Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. Italy Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 54. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Type (2016-2026)
    Figure 55. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Application (2016-2026)
    Figure 56. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Region (2016-2026)
    Figure 57. China Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. South Korea Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. India Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. Southeast Asia Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. Australia Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Type (2016-2026)
    Figure 64. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Application (2016-2026)
    Figure 65. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Country (2016-2026)
    Figure 66. Brazil Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. Argentina Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Type (2016-2026)
    Figure 69. Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Sales Market Share by Application (2016-2026)
    Figure 70. Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Country (2016-2026)
    Figure 71. Turkey Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 72. Saudi Arabia Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. UAE Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. Methodology
    Figure 75. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Recipharm
AMRI3
Patheon
Aenova
Catalent
Amatsigroup
WuXi PharmaTech
Strides Shasun
Piramal
Siegfried

Related Reports

Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 16 Jan 2022

date Medical Care

The Contract Research Organization (CRO) and CDMO for Pharmaceutical market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Product Tags

contract organization cro cdmo for pharmaceutical

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>